We are live on ! Find out more
LABP

Landos Biopharma, Inc. Common Stock

Delisted

LABP was delisted on the 23rd of May, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$21.9M
RI
2
RTW Investments
New York
$6.31M
OMC
3
OUP Management Company
Pennsylvania
$2.7M
BlackRock
4
BlackRock
New York
$767K +$127K +4,988 +11%
Renaissance Technologies
5
Renaissance Technologies
New York
$502K +$431K +16,940 +99%
JP Morgan Chase
6
JP Morgan Chase
New York
$432K -$18.4K -724 -2%
O
7
OrbiMed
New York
$418K
BCM
8
Bridgeway Capital Management
Texas
$235K +$404K +15,900 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$234K -$371K -14,580 -48%
Jacobs Levy Equity Management
10
Jacobs Levy Equity Management
New Jersey
$234K +$404K +15,888 New
Macquarie Group
11
Macquarie Group
Australia
$217K
AI
12
ArchPoint Investors
Florida
$190K
Geode Capital Management
13
Geode Capital Management
Massachusetts
$167K -$1.17K -46 -0.4%
State Street
14
State Street
Massachusetts
$163K +$6.61K +260 +2%
Walleye Capital
15
Walleye Capital
New York
$138K -$29.7K -1,168 -11%
Two Sigma Investments
16
Two Sigma Investments
New York
$109K +$48K +1,887 +34%
Millennium Management
17
Millennium Management
New York
$90K +$155K +6,097 New
Bank of America
18
Bank of America
North Carolina
$83K +$63.8K +2,509 +80%
Northern Trust
19
Northern Trust
Illinois
$67K -$788 -31 -0.7%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$62K +$42.2K +1,660 +65%
Walleye Trading
21
Walleye Trading
New York
$49K -$25.8K -1,015 -23%
Goldman Sachs
22
Goldman Sachs
New York
$29K +$5.01K +197 +11%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$25K +$10.2K +400 +31%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$25K +$43.2K +1,699 New
Charles Schwab
25
Charles Schwab
California
$16K -$9.18K -361 -26%